XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:              
Net income (loss) $ (1,775) $ (1,738) $ (875) [1] $ 1,520 $ (3,513) $ 645  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:              
Depreciation and amortization         509 1,035  
Operating lease asset amortization         1,664 1,734  
Impairment of long-lived assets 9   0   1,078 0  
(Gain) loss on disposal of assets         142 (35)  
Stock-based compensation         411 378  
Deferred income taxes         (220) 624  
Exchange (gain) loss         (3) 134  
Changes in operating assets and liabilities:              
Accounts receivable-trade         (60) (45)  
Inventory         (6,954) 7,183  
Prepaid expenses         (63) 469  
Other current assets         (7) 26  
Accounts payable-trade         834 (675)  
Accrued expenses and other liabilities         (679) (2,339)  
Income taxes, net         (869) (1,541)  
Other assets         (1,664) (218)  
Operating lease liabilities         (1,737) (1,677)  
Total adjustments         (7,618) 5,053  
Net cash provided by (used in) operating activities         (11,131) 5,698  
Cash flows from investing activities:              
Purchase of property and equipment         (285) (136)  
Purchase of short-term investments         (1,697) (10,679)  
Proceeds from sales of assets         1 85  
Proceeds from sales of short-term investments         6,310 1,680  
Net cash provided by (used in) investing activities         4,329 (9,050)  
Cash flows from financing activities:              
Proceeds from long-term debt         402 0  
Payments on long-term debt         0 (8,968)  
Repurchase of treasury stock         0 (724)  
Net cash provided by (used in) financing activities         402 (9,692)  
Effect of exchange rate changes on cash and cash equivalents         (91) 248  
Net decrease in cash and cash equivalents         (6,491) (12,796)  
Cash and cash equivalents, beginning of period   $ 15,905   $ 24,070 15,905 24,070 $ 24,070
Cash and cash equivalents, end of period $ 9,414   $ 11,274   $ 9,414 $ 11,274 $ 15,905
[1] For the three months ended June 30, 2019, there were 2,290 shares, respectively excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in that period.